14
Dec
Q&A with Bob Terbrueggen, President & CEO, DxTerity – Speaker at PMWC 2018 Silicon Valley
Q: What are the challenges that the field of genomic research will face in the next five years?...
14
Dec
Q&A with Mark Kiel, CSO and Co-founder, Genomenon – Speaker at PMWC 2018 Silicon Valley
Q: What are the challenges facing clinical interpretation of NGS data today?...
04
Dec
Note from Dr. Aris Baras, PMWC 2018 SV Genomic Medicine Track Chair
We are entering an era of amazing growth and these technologies and applications will soon be ubiquitous in healthcare and research around the world....
03
Dec
Interview with Hector Rodriguez, Worldwide Health Chief Information Security Officer, Microsoft – Speaker at PMWC 2018 Silicon Valley
The cloud will be the big data platform with the associated machine-learning and artificial intelligence services that will truly enable healthcare to be data-driven...
29
Nov
Interview with Alex Zhavoronkov, CEO of Insilico Medicine – Speaker at PMWC 2018 Silicon Valley
Q: Everyone is talking about the China’s big push into AI. What is happening in China?...
27
Nov
What Can We Learn from NICUs? – Hear from Stephen Kingsmore, President & CEO of Rady Children’s Institute for Genomic Medicine – Speaker at PMWC 2018 Silicon Valley
An example that is likely to become a model, not only for other NICUs, but for efficient whole genome sequencing in the general clinical setting....
26
Nov
Q&A with Emmanuelle Charpentier, Director, Max Planck Institute for Infection Biology, Recipient of the PMWC 2018 Luminary Award
Q: Can you describe some of the initial challenges you faced in understanding how the CRISPR system works?...
26
Nov
Q&A with Alan Ashworth, President, UCSF Helen Diller Family Comprehensive Cancer Center, Recipient of the PMWC 2018 Pioneer Award
Q: Can you share some of the latest discoveries in new drugs and diagnostics that scientists at the Helen Diller Family Comprehensive Cancer Center are working on?...
20
Nov
Challenges of Marrying a Drug with Diagnostics: PMWC Interview with Dan Snyder, President and CEO of MolecularMD – Speaker at PMWC 2018 Silicon Valley
Q: What challenges are there when it comes to defining the commercialization strategy for when marrying a drug with a diagnostics?...
16
Nov
Dealing with Metastatic Breast Cancer – Experiencing the Caregiver’s Journey Firsthand @ PMWC 2018 Silicon Valley
Anil Sethi: “It’s fine to talk about cutting edge immunotherapy, biomarkers for early detection of disease, and the implications of ‘big data’. But there are dirty little secrets surrounding big-data in healthcare…. we’ve got to think much smaller. Small data; N-of-1; The individual. Collected patient...
